[EN] 4-(1-(SULFONYL)-1H-INDOL-2-YL)-4-(HYDROXY)-CYCLOHEXA-2,5-DIENONE COMPOUNDS AND ANALOGS THEREOF AS THERAPEUTIC AGENTS<br/>[FR] COMPOSES DE 4-(1-(SULFONYL)-1H-INDOL-2-YL)-4-(HYDROXY)-CYCLOHEXA-2,5-DIENONE ET ANALOGUES DE CEUX-CI UTILISES COMME AGENTS THERAPEUTIQUES
申请人:CANCER REC TECH LTD
公开号:WO2004056361A1
公开(公告)日:2004-07-08
This invention pertains to certain 4-(1-(sulfonyl)-1H-indol-2-yl)-4-(hydroxy)-cyclohexa-2,5-dienone compounds, and analogs thereof, including compounds of the following formula, which are, inter alia, antiproliferative agents, anticancer agents, and/or thioredoxin/thioredoxin reductase inhibitors: formula (I) wherein: Ar is a 1-(sulfonyl)-1H-indol-2-yl group; the bond marked alpha is independently: (a) a single bond; or: (b) a double bond; the bond marked beta is independently: (a) a single bond; or: (b) a double bond; the group -OR is independently: (a) -OH; (b) an ether group (e.g., -OMe); or: (c) an acyloxy (i.e., reverse ester) group (e.g., -OC(=O)Me); each of R<2>, R<3>, R<5>, and R<6>, is independently a ring substituent and is: (a) H; (b) a monovalent monodentate substituent; or: (c) a ring substituent which, together with an adjacent ring substituent, and together with the ring atoms to which these ring substituents are attached, form a fused ring; and pharmaceutically acceptable salts, esters, amides, solvates, hydrates, and protected forms thereof. The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, for example, in the treatment of proliferative conditions, (e.g., cancer), and/or conditions mediated by thioredoxin/thioredoxin reductase.
本发明涉及某些4-(1-(磺酰基)-1H-吲哚-2-基)-4-(羟基)-环己-2,5-二酮化合物及其类似物,包括以下式的化合物,其中这些化合物是抗增殖剂、抗癌剂和/或硫代雷帕敏/硫代雷帕敏还原酶抑制剂:式(I)其中:Ar是1-(磺酰基)-1H-吲哚-2-基;标记为α的键独立地是:(a) 单键;或:(b) 双键;标记为β的键独立地是:(a) 单键;或:(b) 双键;-OR基独立地是:(a) -OH;(b) 一个醚基团(例如,-OMe);或:(c) 一个酰氧基(即,反酯基)(例如,-OC(=O)Me);R2、R3、R5和R6中的每一个独立地是一个环取代基,可以是:(a) H;(b) 一价单齿取代基;或:(c) 一个环取代基,与相邻的环取代基一起,以及与这些环取代基连接的环原子一起形成融合环;以及其药学上可接受的盐、酯、酰胺、溶剂合物、水合物和受保护形式。本发明还涉及含有这些化合物的药物组合物,以及这些化合物和组合物的用途,无论是在体外还是体内,例如,在治疗增殖性疾病(例如,癌症)和/或由硫代雷帕敏/硫代雷帕敏还原酶介导的疾病方面。